In another recent study (Zhang et al., 2021), Zhang et la have revealed that Bawei Chenxiang Wan as a Tibetan herbal medicine that prevents cardiac hypertrophy in isoprenaline-induced rats by activating AMPK/PPAR-α signaling. Here, PRKAA2 is linked to cardiac hypertrophy.